Literature DB >> 24814804

Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin.

S Joseph Sirintrapun1, Aaron U Blackham2, Greg Russell3, Konstantinos Votanopoulos2, John H Stewart2, Perry Shen2, Edward A Levine2, Kim R Geisinger4, Simon Bergman5.   

Abstract

Significance of signet ring cells in mucinous adenocarcinoma of the peritoneum from appendiceal origin has never been specifically studied. We retrospectively reviewed cases of mucinous adenocarcinoma of the peritoneum from appendiceal origin (n = 55) and collected clinical follow-up data. Signet ring cells were identified in 29 of 55 cases. No low-grade mucinous adenocarcinoma case (n = 11) had signet ring cells, whereas 29 of 44 high-grade mucinous adenocarcinoma cases did. Cases of high-grade mucinous adenocarcinoma were subdivided into 3 groups: (1) high-grade mucinous adenocarcinoma without signet ring cells (n = 15), (2) high-grade mucinous adenocarcinoma with signet ring cells only within mucin pools (n = 20), and (3) high-grade mucinous adenocarcinoma with signet ring cells invading tissue (n = 9). Overall survival (OS) and progression-free survival were subsequently evaluated. Five-year OS for cases of high-grade mucinous adenocarcinoma without signet ring cells and high-grade mucinous adenocarcinoma with signet ring cells within mucin pools were similar at 31.8% (SE, 14.4%) and 35.8% (SE, 13.9%), respectively. A significant survival difference was seen for cases of high-grade mucinous adenocarcinoma with signet ring cells invading tissue with a median OS of 0.5 years versus 2.9 and 2.4 years (P = .04 and P = .03), respectively, for cases of high-grade mucinous adenocarcinoma without signet ring cells and high-grade mucinous adenocarcinoma with signet ring cells within mucin pools. Finding signet ring cells floating in extracellular mucin pools made no prognostic difference when compared with cases of high-grade mucinous adenocarcinoma without signet ring cells. In contrast, high-grade mucinous adenocarcinoma with signet ring cells invading tissue was significant for worse survival, and thus, we propose reporting signet ring cell tissue invasion particularly when extensive.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Appendix; Mucinous adenocarcinoma; Peritoneal mucinous carcinomatosis; Pseudomyxoma peritonei; Signet ring carcinoma; Signet ring cells

Mesh:

Year:  2014        PMID: 24814804      PMCID: PMC4107056          DOI: 10.1016/j.humpath.2014.03.007

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  Importance of histologic subtype in the staging of appendiceal tumors.

Authors:  Kiran K Turaga; Sam G Pappas; T Clark Gamblin
Journal:  Ann Surg Oncol       Date:  2012-05       Impact factor: 5.344

Review 2.  Pleuropulmonary involvement in pseudomyxoma peritonei: morphologic assessment and literature review.

Authors:  Kim R Geisinger; Edward A Levine; Perry Shen; Robert F Bradley
Journal:  Am J Clin Pathol       Date:  2007-01       Impact factor: 2.493

3.  Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix.

Authors:  C H Lieu; L A Lambert; R A Wolff; C Eng; N Zhang; S Wen; S Rafeeq; M Taggart; K Fournier; R Royal; P Mansfield; M J Overman
Journal:  Ann Oncol       Date:  2011-06-08       Impact factor: 32.976

Review 4.  Mucinous neoplasms of the appendix and peritoneum.

Authors:  Nicole C Panarelli; Rhonda K Yantiss
Journal:  Arch Pathol Lab Med       Date:  2011-10       Impact factor: 5.534

5.  Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.

Authors:  Dario Baratti; Shigeki Kusamura; Daisuke Nonaka; Antonello Domenico Cabras; Barbara Laterza; Marcello Deraco
Journal:  Ann Surg       Date:  2009-02       Impact factor: 12.969

6.  A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status.

Authors:  Christian Wittekind; Carolyn Compton; Phil Quirke; Iris Nagtegaal; Susanne Merkel; Paul Hermanek; Leslie H Sobin
Journal:  Cancer       Date:  2009-08-01       Impact factor: 6.860

7.  Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".

Authors:  B M Ronnett; C M Zahn; R J Kurman; M E Kass; P H Sugarbaker; B M Shmookler
Journal:  Am J Surg Pathol       Date:  1995-12       Impact factor: 6.394

8.  Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence.

Authors:  Reetesh K Pai; Andrew H Beck; Jeffrey A Norton; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2009-10       Impact factor: 6.394

9.  Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Authors:  Dario Baratti; Shigeki Kusamura; Daisuke Nonaka; Martin Langer; Salvatore Andreola; Miriam Favaro; Cecilia Gavazzi; Barbara Laterza; Marcello Deraco
Journal:  Ann Surg Oncol       Date:  2007-11-28       Impact factor: 5.344

10.  Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis.

Authors:  Ulrich Nitsche; Anina Zimmermann; Christoph Späth; Tara Müller; Matthias Maak; Tibor Schuster; Julia Slotta-Huspenina; Samuel A Käser; Christoph W Michalski; Klaus-Peter Janssen; Helmut Friess; Robert Rosenberg; Franz G Bader
Journal:  Ann Surg       Date:  2013-11       Impact factor: 12.969

View more
  9 in total

1.  Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative.

Authors:  Nick C Levinsky; Mackenzie C Morris; Koffi Wima; Jeffrey J Sussman; Syed A Ahmad; Jordan M Cloyd; Charles Kimbrough; Keith Fournier; Andrew Lee; Sean Dineen; Sophie Dessureault; Jula Veerapong; Joel M Baumgartner; Callisia Clarke; Mohammad Y Zaidi; Charles A Staley; Shishir K Maithel; Jennifer Leiting; Travis Grotz; Laura Lambert; Ryan J Hendrix; Sean Ronnekleiv-Kelly; Courtney Pokrzywa; Mustafa Raoof; Oliver S Eng; Fabian M Johnston; Jonathan Greer; Sameer H Patel
Journal:  J Gastrointest Surg       Date:  2019-08-19       Impact factor: 3.452

Review 2.  New insights in the pathology of peritoneal surface malignancy.

Authors:  Norman John Carr
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 3.  The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies.

Authors:  Mackenzie C Morris; Jordan M Cloyd; John Hays; Sameer H Patel
Journal:  J Gastrointest Surg       Date:  2020-08-17       Impact factor: 3.452

Review 4.  Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens-A review and evidence-based guide.

Authors:  Aditi Bhatt; Suniti Mishra; Loma Parikh; Sandeep Sheth; Imran Gorur
Journal:  Indian J Surg Oncol       Date:  2019-03-19

Review 5.  Peritoneal Metastases from Appendiceal Cancer.

Authors:  Konstantinos I Votanopoulos; Perry Shen; Aleksander Skardal; Edward A Levine
Journal:  Surg Oncol Clin N Am       Date:  2018-07       Impact factor: 3.495

Review 6.  Limited, local, extracolonic spread of mucinous appendiceal adenocarcinoma after perforation with formation of a malignant appendix-to-sigmoid fistula: Case report and literature review.

Authors:  Seifeldin Hakim; Mitual Amin; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

7.  Overinterpretation is common in pathological diagnosis of appendix cancer during patient referral for oncologic care.

Authors:  Mark A Valasek; Irene Thung; Esha Gollapalle; Alexey A Hodkoff; Kaitlyn J Kelly; Joel M Baumgartner; Vera Vavinskaya; Grace Y Lin; Ann P Tipps; Mojgan V Hosseini; Andrew M Lowy
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

8.  Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade.

Authors:  Travis Edward Grotz; Richard E Royal; Paul F Mansfield; Michael James Overman; Gary N Mann; Kristen Ashlee Robinson; Karen A Beaty; Safiea Rafeeq; Auerlio Matamoros; Michelle W Taggart; Keith Francis Fournier
Journal:  World J Gastrointest Oncol       Date:  2017-09-15

9.  Defining stage in mucinous tumours of the appendix with peritoneal dissemination: the importance of grading terminology: systematic review.

Authors:  L Martín-Román; P Lozano; W Vásquez; N Palencia; Y Gómez; M J Fernández-Aceñero; L González-Bayón
Journal:  BJS Open       Date:  2021-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.